GenoMethods - Biotechnology, Bioinformatics & AI in Biology

Fresenius takes full control of mAbxience in decisive biosimilars move

Fresenius SE & Co. KGaA has acquired the remaining 45% of mAbxience from Insud Pharma, consolidating its grip on the biosimilars platform and setting the stage for future portfolio expansion.

By Vivian Lin · September 30, 2026, 11:04 PM · 4 mins read

Biotech Companies & Pipelines

Tresalis takes majority control of Vyrao in strategic beauty sector move

By Vivian Lin

Genomics & Multiomics

University of Kentucky lab chases the super tomato: nutrition, flavor, and disease resistance in focus

By Adrian Cole

AI in Biology

First patient receives AI-designed CAR T cell therapy for ovarian cancer

By Elena MacLeod

Biotech Companies & Pipelines

Xeris Biopharma jumps as H Lundbeck eyes possible buyout

By Vivian Lin

IN-DEPTH REPORTING

Biotech Companies & Pipelines

Earth Science Tech pushes into California with Meduvo buy, eyes 34-state pharmacy network

Earth Science Tech Inc. has acquired Meduvo LLC, opening a California hub and expanding its pharmacy network to 34 U.S. jurisdictions. The company aims for sterile-compounding certification by 2028.

By Vivian Lin · September 30, 2026, 11:02 PM

Bioinformatics Methods & Tools

Biostatistics and bioinformatics shape Africa’s genomics policy

September 30, 2026, 8:46 PM

Cell & Gene Therapy

Cell and Gene Therapy International Europe 2026 shifts manufacturing spotlight to Berlin

September 30, 2026, 6:44 PM

BIOTECHNOLOGY NEWS & ANALYSIS >

Clinical Trials & Evidence

CAR T cell therapy triggers remission in severe rheumatoid arthritis

A clinical trial at Charité - Universitätsmedizin Berlin has used CAR T cell therapy to push severe, treatment-resistant rheumatoid arthritis into remission for some patients.

By Elena MacLeod · September 30, 2026, 8:37 AM

Translational Research

Biotechnology News & Analysis

Beam Therapeutics sues YolTech and Serapha Bio over alleged gene editing secrets theft

September 30, 2026, 12:53 AM

Clinical Trials & Evidence

Patients reclaim their future as gene and cell therapies rewrite cancer treatment

September 29, 2026, 10:42 PM

Biotechnology, Decoded

GenoMethods explains biotechnology from method to medicine to market, connecting scientific evidence, clinical development, companies and the technologies shaping future health.

TOP STORIES

Fresenius takes full control of mAbxience in decisive biosimilars move

Tresalis takes majority control of Vyrao in strategic beauty sector move

University of Kentucky lab chases the super tomato: nutrition, flavor, and disease resistance in focus

First patient receives AI-designed CAR T cell therapy for ovarian cancer

Xeris Biopharma jumps as H Lundbeck eyes possible buyout

IN-DEPTH REPORTING

Earth Science Tech pushes into California with Meduvo buy, eyes 34-state pharmacy network

Biostatistics and bioinformatics shape Africa’s genomics policy

Cell and Gene Therapy International Europe 2026 shifts manufacturing spotlight to Berlin

FEATURED STORIES

Biodeal Pharmaceuticals takes over Paonta Sahib plant in Rs 400 crore injectable push

UC San Diego opens new center to crack the biology of polysubstance addiction

Immix Biopharma nears 98 percent complete response in pivotal AL amyloidosis trial

Novo Nordisk grabs global rights to Hengrui Pharma’s oral GLP-1 GIP drug in $2.6 billion deal

Origin Genomics tests embryo gene editing to stop inherited disease

Sun Pharma plans $1 billion rupee bond to replace Organon deal loan

BIOTECHNOLOGY NEWS & ANALYSIS >

CAR T cell therapy triggers remission in severe rheumatoid arthritis

CAR T cells clear the way for kidney transplants in highly sensitized patients

Novo Nordisk grabs UBT251 rights to keep lead in obesity drug race

CLINICAL TRIALS & EVIDENCE >

Descartes 08 retreatment brings lasting relief for myasthenia gravis patients

Beam Therapeutics sues YolTech and Serapha Bio over alleged gene editing secrets theft

Patients reclaim their future as gene and cell therapies rewrite cancer treatment

Biotechnology, Decoded